Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease
- 1 October 2008
- journal article
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 42 (5) , 720-728
Abstract
Parkinson’s disease is a complex disorder that is characterized by progressive degeneration of nigrostriatal dopaminergic neurons. Its development is determined by the interaction between the genetic constitution of a body and environmental factors. Analysis of the genes associated with monogenic forms of Parkinson’s disease implicated proteasomal degradation, differentiation of dopaminergic neurons, mitochondrial dysfunction, and oxidative damage in its pathogenesis. The review considers ample data that suggest a key role for mitochondrial dysfunction and oxidative stress.Keywords
This publication has 89 references indexed in Scilit:
- Mitochondrial Fusion and Fission in MammalsAnnual Review of Cell and Developmental Biology, 2006
- Targeting programmed cell death in neurodegenerative diseasesNature Reviews Neuroscience, 2003
- An inflammatory review of Parkinson’s diseaseProgress in Neurobiology, 2002
- The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in MiceJournal of Biological Chemistry, 2002
- Chronic systemic pesticide exposure reproduces features of Parkinson's diseaseNature Neuroscience, 2000
- Familial aggregation of Parkinson’s diseaseNeurology, 1999
- Genetics of Parkinson's diseaseHuman Molecular Genetics, 1997
- Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23Science, 1996
- Neuropathology of Parkinsonʼs DiseaseJournal of Neuropathology & Experimental Neurology, 1996
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983